ArticleJournal of hematopathology2025
A case of acid sphingomyelinase deficiency type B with prominent histiocytes with engulfed nucleated cells and compound heterozygosity.
Article in Journal of hematopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acid sphingomyelinase deficiency type B (ASMD-B), also known as Niemann-Pick type B (NPB), is caused by inherited mutations in acid sphingomyelinase that results in accumulation of sphingomyelin and other lipids in monocytes/macrophages leading to splenomegaly, hepatomegaly, and/or cytopenias that typically manifest in mid-childhood. Microscopic examination of bone marrow aspirate and core biopsy specimens frequently reveals the presence of foamy histiocytes. In this case report, we describe a case of a 21-year-old woman who presented with progressive hepatosplenomegaly, gastroparesis, weight loss, and a neutrophilic leukocytosis who was found to have foamy histiocytes with engulfed nucleated cells compatible with emperipolesis or hemophagocytosis. Based on the constellation of clinicopathologic findings, a lysosomal storage disorder was suspected and subsequent genetic testing revealed the presence of two SMPD1 variants, one known pathogenic (c.1829_1831del, p.Arg610del) and one variant of unknown significance (VUS) (c.872G > A, p.Arg291His) (Table 1). Follow-up testing found that acid sphingomyelinase (ASM) activity was low (0.11 nmol/h/mg, reference value > 0.32 nmol/h/mg), consistent with enzyme dysfunction and supportive of the diagnosis of NPB. The patient was started on enzyme replacement therapy with olipudase alfa. To our knowledge, this is the first reported case of NPB in which foamy histiocytes with engulfed nucleated cells were a prominent feature in the bone marrow aspirate. One recent study reported finding emperipolesis in some cases of ASMD. Thus, this may be an uncommon but recurrent finding in some NPB patients.
Indexed as
Identifiers
40343567What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.